
|Articles|September 16, 2021
Pharmacy Clinical Pearl of the Day: Multiple Sclerosis
Author(s)Saro Arakelians, PharmD
In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers, causing deterioration of the nerves.
Advertisement
Clinical Pearl of the Day: Multiple Sclerosis
Multiple sclerosis (MS) is a disease of the brain and spinal cord.
Explanation:
- In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers, causing deterioration of the nerves.
- Symptoms of MS include numbness, weakness, tremor, lack of coordination, blurry vision, double vision, slurred speech, fatigues, dizziness, tingling, and problems with bowel and bladder function.
- Diagnosis could include blood test, spinal tap, MRI, and an evoked potential test.
- Treatment options may include Interferon beta, Copaxone, Gilenya, Tecfidera, Vumerity, Aubagio, Mayzent, Mavenclad, Ocrevus, Tysarbi, Lemtrada, and physical therapy.
References
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
2
Amid Mounting Pressure, FDA Commissioner Marty Makary Resigns
3
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
4
Sonrotoclax Approval Delivers a Long-Awaited New Option for Relapsed or Refractory Mantle Cell Lymphoma
5


































































































































